Business ❯ Finance ❯ Corporate Finance
Pfizer Financial Performance Novo Nordisk Eli Lilly GSK AstraZeneca Earnings Reports Sales Performance Merck & Co Inc Dr Reddy's Laboratories Novartis Merck Revenue Growth Regeneron Pharmaceuticals Glenmark Pharmaceuticals Aurobindo Pharma Drug Development Merck & Co. Company Performance Kiniksa Pharmaceuticals Dr. Reddy's Laboratories Biotechnology Cipla Ltd Expense Management Vaccine Development Dermatology Earnings Calls Dividend Policy Emcure Pharmaceuticals Revenue Analysis Bristol Myers Squibb Employee Benefits Annual Results GlaxoSmithKline Pharmaceuticals Product Performance Pfizer Inc. AbbVie Organon Quarterly Results Madrigal Pharmaceuticals Johnson & Johnson Fennec Pharmaceuticals Ajanta Pharma Sanofi BioSyent Inc. Drug Sales Divi's Laboratories Clinical Trials Obesity Treatments Amylyx Pharmaceuticals
Higher net debt from recent deals and shareholder payouts raises reliance on upcoming trial readouts and the Myricx Bio acquisition to sustain momentum.
